Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Lymphoma, Extranodal NK-T-Cell × Positron-Emission Tomography × Clear all

Sponsor

Conditions

Prostatic Neoplasms 6 Lymphoma, Non-Hodgkin 3 Neoplasms 2 Neoplasm Metastasis 2 Lymphoma 2 Disease 2 Carcinoma, Hepatocellular 2 Breast Neoplasms 2 Vulvar Neoplasms 1 Vulvar Diseases 1 Vasculitis 1 Uterine Cervical Neoplasms 1 Uterine Cervical Dysplasia 1 Urinary Bladder Neoplasms 1 Triple Negative Breast Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Smoking Cessation 1 Papillomavirus Infections 1 Osteomyelitis 1 Nose Neoplasms 1 Myelodysplastic Syndromes 1 Multiple Pulmonary Nodules 1 Multiple Myeloma 1 Melanoma 1 Lymphoma, Large-Cell, Anaplastic 1 Lymphoma, Large B-Cell, Diffuse 1 Lymphoma, Follicular 1 Lung Neoplasms 1 Liver Neoplasms 1 Leukemia 1

Interventions

fludarabine phosphate 16 Cyclophosphamide 13 Peripheral Blood Stem Cell Transplantation 12 Whole-Body Irradiation 11 Mycophenolic Acid 11 Tacrolimus 10 Antilymphocyte Serum 10 Busulfan 9 Rituximab 7 Etoposide 6 Cyclosporine 6 Methotrexate 5 thymoglobulin 4 Melphalan 4 Flow Cytometry 4 Therapeutics 3 Lenalidomide 3 In Situ Hybridization, Fluorescence 3 Immunohistochemistry 3 Gene Expression Profiling 3 Filgrastim 3 Everolimus 3 Carboplatin 3 Amplified Fragment Length Polymorphism Analysis 3 Alemtuzumab 3 Vorinostat 2 Vincristine 2 Sirolimus 2 Radiotherapy 2 Prednisone 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡